| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007351950 |
| P356 | DOI | 10.1007/S13181-016-0588-Y |
| P8608 | Fatcat ID | release_bripl6vm3fccjg3bwsugiwdojy |
| P932 | PMC publication ID | 5135684 |
| P698 | PubMed publication ID | 27752985 |
| P50 | author | Kavita M. Babu | Q47818963 |
| Abhisheak Sharma | Q48104685 | ||
| P2093 | author name string | Christopher R McCurdy | |
| Edward W Boyer | |||
| Bonnie A Avery | |||
| Alicia G Lydecker | |||
| P2860 | cites work | Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth) | Q24616893 |
| Regulations of opioid dependence by opioid receptor types | Q28214041 | ||
| Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands | Q28215114 | ||
| Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton | Q28236193 | ||
| Indole alkaloids of a Thai medicinal herb, Mitragyna speciosa, that has opioid agonistic effect in guinea-pig ileum | Q28240023 | ||
| Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa | Q28245639 | ||
| Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes | Q28542837 | ||
| A study of kratom eaters in Thailand | Q33868856 | ||
| The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy | Q34094104 | ||
| Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure | Q34111502 | ||
| Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa Korth in rodent. | Q34126830 | ||
| Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression | Q34139973 | ||
| Mitragyna speciosa, A Psychoactive Tree from Southeast Asia with Opioid Activity | Q34148010 | ||
| A drug toxicity death involving propylhexedrine and mitragynine | Q34158283 | ||
| Ethnopharmacology of kratom and the Mitragyna alkaloids | Q34178458 | ||
| Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E₂ production induced by lipopolysaccharide in RAW264.7 macrophage cells | Q34180011 | ||
| Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa) | Q34181061 | ||
| Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study | Q34263025 | ||
| From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction | Q34315155 | ||
| Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. | Q34315630 | ||
| The pharmacology and toxicology of kratom: from traditional herb to drug of abuse | Q34499777 | ||
| Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries | Q34504233 | ||
| A drug fatality involving Kratom | Q34644236 | ||
| Opioid receptors and legal highs: Salvia divinorum and Kratom | Q34747694 | ||
| Nutritional supplements and doping | Q34751934 | ||
| Russian roulette with unlicensed fat-burner drug 2,4-dinitrophenol (DNP): evidence from a multidisciplinary study of the internet, bodybuilding supplements and DNP users. | Q36165586 | ||
| Contamination of dietary supplements and positive drug tests in sport | Q36272731 | ||
| Nutritional supplements cross-contaminated and faked with doping substances | Q37194737 | ||
| Hydromorphone: evolving to meet the challenges of today's health care environment | Q38167492 | ||
| Antioxidant value and antiproliferative efficacy of mitragynine and a silane reduced analogue | Q38969761 | ||
| The alkaloids of Mitragyna with special reference to those of Mitragyna speciosa, Korth | Q39946742 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence. | Q42924541 | ||
| Simultaneous determination of yohimbine, sildenafil, vardenafil and tadalafil in dietary supplements using high-performance liquid chromatography-tandem mass spectrometry | Q43038706 | ||
| Analysis of adulterated herbal medicines and dietary supplements marketed for weight loss by DOSY 1H-NMR. | Q43076522 | ||
| Monitoring of 29 weight loss compounds in foods and dietary supplements by LC-MS/MS. | Q43312448 | ||
| Determination of PDE-5 inhibitors and appetite suppressants in adulterated dietary supplements using LC/PDA and LC/MS. | Q43316704 | ||
| A new approach to determining pharmacologic adulteration of herbal weight loss products | Q43347466 | ||
| Simultaneous determination of 38 phosphodiestrase-5 inhibitors in illicit erectile dysfunction products by liquid chromatography-electrospray ionization-tandem mass spectrometry | Q43840503 | ||
| Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity | Q44334204 | ||
| Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors | Q44343174 | ||
| Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice | Q44348657 | ||
| Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids - results of an international study. | Q44778074 | ||
| Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV. | Q45136382 | ||
| Screening for multiple weight loss and related drugs in dietary supplement materials by flow injection tandem mass spectrometry and their confirmation by liquid chromatography tandem mass spectrometry | Q45249994 | ||
| Isolation and structural characterization of two tadalafil analogs found in dietary supplements | Q45530890 | ||
| Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC-MS/TOF. | Q45961555 | ||
| Analysis of six synthetic adulterants in herbal weight-reducing dietary supplements by LC electrospray ionization-MS. | Q46527866 | ||
| Unintentional doping through the use of contaminated nutritional supplements. | Q46697861 | ||
| Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa | Q46708404 | ||
| A rapid, quantitative liquid chromatography-mass spectrometry screening method for 71 active and 11 natural erectile dysfunction ingredients present in potentially adulterated or counterfeit products | Q46901416 | ||
| Identification of a new tadalafil analogue found in a dietary supplement | Q46973877 | ||
| Anorectic sibutramine detected in a Chinese herbal drug for weight loss. | Q47328003 | ||
| Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detection. | Q47339568 | ||
| Active pharmaceutical ingredients detected in herbal food supplements for weight loss sampled on the Dutch market. | Q47434915 | ||
| Mitragynine 'Kratom' related fatality: a case report with postmortem concentrations | Q48150887 | ||
| Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems | Q48830458 | ||
| Evaluation of antioxidant and antibacterial activities of aqueous, methanolic and alkaloid extracts from Mitragyna speciosa (Rubiaceae family) leaves. | Q50052122 | ||
| Abuse potential and adverse cognitive effects of mitragynine (kratom). | Q50631913 | ||
| A coincidence of addiction to "Kratom" and severe primary hypothyroidism. | Q52299208 | ||
| Identification of a novel sildenafil analogue in an adulterated herbal supplement. | Q53210207 | ||
| Simultaneous analysis of mitragynine, 7-hydroxymitragynine, and other alkaloids in the psychotropic plant “kratom” (Mitragyna speciosa) by LC-ESI-MS | Q56864611 | ||
| Ethnopharmacology of kratom and the Mitragyna alkaloids | Q56864613 | ||
| Screening and determination of sibutramine in adulterated herbal slimming supplements by HPTLC-UV densitometry | Q58864968 | ||
| Liquid chromatography–high resolution mass spectrometry (LC–HRMS) determination of stimulants, anorectic drugs and phosphodiesterase 5 inhibitors (PDE5I) in food supplements | Q59652775 | ||
| A New Indole Alkaloid, 7 alpha-Hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand | Q79604804 | ||
| Effect of Mitragyna speciosa aqueous extract on ethanol withdrawal symptoms in mice | Q79868285 | ||
| Dietary supplements for athletes: emerging trends and recurring themes | Q82852519 | ||
| Development of a liquid chromatography tandem mass spectrometry method for simultaneous determination of eight adulterants in slimming functional foods | Q84908425 | ||
| Detection and structure elucidation of hydroxythiovardenafil as an adulterant in a herbal dietary supplement | Q85661322 | ||
| Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors | Q86698099 | ||
| Simultaneous screening and determination of 18 illegal adulterants in herbal medicines and health foods for male sexual potency by ultra-fast liquid chromatography-electrospray ionization tandem mass spectrometry | Q87355660 | ||
| Analysis of illicit dietary supplements sold in the Italian market: identification of a sildenafil thioderivative as adulterant using UPLC-TOF/MS and GC/MS | Q87812169 | ||
| First identification and quantification of lorcaserin in an herbal slimming dietary supplement | Q88031761 | ||
| Identification of mitragynine and O-desmethyltramadol in Kratom and legal high products sold online | Q88150419 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mitragyna speciosa | Q139698 |
| P304 | page(s) | 341-349 | |
| P577 | publication date | 2016-10-17 | |
| P1433 | published in | Journal of Medical Toxicology | Q6295541 |
| P1476 | title | Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine | |
| P478 | volume | 12 |
| Q93028216 | Current regulatory guidelines and resources to support research of dietary supplements in the United States |
| Q61808214 | Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic |
| Q89998071 | Evaluating kratom alkaloids using PHASE |
| Q97886905 | Kratom instrumentalization for severe pain self-treatment resulting in addiction - A case report of acute and chronic subjective effects |
| Q61799492 | Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health |
| Q41462770 | Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs |
| Q58096508 | Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity |
| Q47286603 | Pharmacologic and clinical assessment of kratom |
| Q90370217 | Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results from an Online Survey |
| Q93172030 | Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry |
Search more.